A Case of Rapidly Progressing Hepatocellular Carcinoma after Administration of JAK Inhibitors to Treat Rheumatoid Arthritis
We report a case of rapidly progressing hepatocellular carcinoma after administration of Janus kinase (JAK) inhibitors to treat rheumatoid arthritis. A 76-year-old man was referred to our Department for pain in multiple joints and was diagnosed with rheumatoid arthritis. Blood tests revealed elevate...
Saved in:
| Main Authors: | Rioko Migita, Yasutaka Kimoto, Junki Hiura, Yuta Okumura, Takahiko Horiuchi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2022/6852189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment
by: Xuyang Xia, et al.
Published: (2025-03-01) -
A single-cell RNA-seq dataset of synovial fluid from rheumatoid arthritis treated with TNF-α/JAK inhibitor
by: Chenjia He, et al.
Published: (2025-06-01) -
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort study
by: Adeline Ruyssen-Witrand, et al.
Published: (2025-01-01) -
Effects of IL-6, JAK, TNF inhibitors, and CTLA4-Ig on knee symptoms in patients with rheumatoid arthritis
by: Koichi Murata, et al.
Published: (2024-07-01) -
Vascular synovial phenotype indicates poor response to JAK inhibitors in rheumatoid arthritis patients: a pilot study
by: Mengxia Liu, et al.
Published: (2024-11-01)